Deka Biosciences, a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced that the U.S. Food and Drug...
Transgene , a biotech company that designs and develops virus-based immunotherapeutics against cancer, will host an R&D event for investors and research analysts in...
Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...
Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected reduce and manage viral respiratory tract...
